Pierre Fabre
Quick facts
Marketed products
- Navelbine · Oncology
Navelbine works by binding to the Substance-K receptor, disrupting microtubule formation and inhibiting cell division.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Pierre Fabre
What are Pierre Fabre's marketed drugs?
Top marketed products include Navelbine.
Related
- Navelbine · Oncology
- Sector hub: All tracked pharma companies